Related Experiment Videos
Equine herpesvirus 1 myeloencephalopathy
1Department of Medicine and Epidemiology, University of California, Davis, School of Veterinary Medicine, USA.
The Veterinary Clinics of North America. Equine Practice
|April 1, 1997
Summary
Equine herpesvirus 1 (EHV-1) can cause myeloencephalopathy, leading to neurological signs in horses. Prevention is challenging due to latent infections and ineffective vaccines against neurological disease.
Area of Science:
- Equine Neurology
- Veterinary Virology
- Infectious Disease Epidemiology
Background:
- Equine herpesvirus 1 (EHV-1) uncommon but severe cause of myeloencephalopathy.
- Neurological signs stem from vasculitis and thrombosis, causing hemorrhagic lesions.
Purpose of the Study:
- Review pathogenesis, pathology, clinical signs, diagnosis, and treatment of EHV-1 myeloencephalopathy.
- Discuss prevention and control strategies for EHV-1 infections.
Main Methods:
- Literature review of EHV-1 myeloencephalopathy.
- Synthesis of epidemiological and clinical findings.
Main Results:
- Typical signs include ataxia, paresis, urinary incontinence with sudden onset.
- Outbreaks often involve multiple horses with a history of fever or respiratory illness.
- Variability exists in epidemiological and clinical presentations.
Conclusions:
- EHV-1 myeloencephalopathy poses significant risks to horse populations.
- Effective prevention is hindered by asymptomatic carriers and vaccine limitations.
- Integrated management strategies are crucial for controlling EHV-1.